DE69014141D1 - Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel. - Google Patents

Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel.

Info

Publication number
DE69014141D1
DE69014141D1 DE69014141T DE69014141T DE69014141D1 DE 69014141 D1 DE69014141 D1 DE 69014141D1 DE 69014141 T DE69014141 T DE 69014141T DE 69014141 T DE69014141 T DE 69014141T DE 69014141 D1 DE69014141 D1 DE 69014141D1
Authority
DE
Germany
Prior art keywords
antibacterial agents
benzimidazole derivatives
stands
hydrogen
campylobacter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69014141T
Other languages
English (en)
Other versions
DE69014141T2 (de
Inventor
Tomoyuki Iwahi
Hiroshi Satoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26370930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69014141(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DE69014141D1 publication Critical patent/DE69014141D1/de
Application granted granted Critical
Publication of DE69014141T2 publication Critical patent/DE69014141T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
DE69014141T 1989-02-10 1990-02-06 Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel. Expired - Lifetime DE69014141T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3237489 1989-02-10
JP23923389 1989-09-15

Publications (2)

Publication Number Publication Date
DE69014141D1 true DE69014141D1 (de) 1994-12-22
DE69014141T2 DE69014141T2 (de) 1995-05-24

Family

ID=26370930

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69014141T Expired - Lifetime DE69014141T2 (de) 1989-02-10 1990-02-06 Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel.

Country Status (10)

Country Link
US (1) US5013743A (de)
EP (1) EP0382489B1 (de)
AT (1) ATE114114T1 (de)
CA (1) CA2009741C (de)
DE (1) DE69014141T2 (de)
DK (1) DK0382489T3 (de)
ES (1) ES2066120T3 (de)
FI (2) FI100168B (de)
GR (1) GR3014973T3 (de)
NO (1) NO900639L (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338723A (en) * 1989-10-13 1994-08-16 Merck & Co., Inc. Fibrinogen receptor antagonists
JPH06500547A (ja) * 1990-09-14 1994-01-20 ビイク　グルデン　ロンベルク　ヒエーミツシエ　フアブリーク　ゲゼルシヤフト　ミツト　ベシユレンクテル　ハフツング ピリジルメチルスルフィニル―１ｈ―ベンゾイミダゾール誘導体のヘリコバクターにより起こされる病気の治療のための使用
TW209174B (de) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
IS3990A (is) * 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
PL307026A1 (en) * 1992-07-08 1995-05-02 Monsanto Co Method of producing ppaliative effect in respect to swine gastric ulcers
AU674015B2 (en) * 1992-07-28 1996-12-05 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
ES2087623T3 (es) * 1992-08-21 1996-07-16 Eisai Co Ltd Derivados de bencimidazol como agente antimicrobiano contra campylobacter pylon.
AU5699594A (en) * 1992-12-10 1994-07-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of alkylthiopyridines for controlling helicobacter bacteria
JPH06298611A (ja) * 1993-04-16 1994-10-25 Nippon Chemiphar Co Ltd 抗菌剤
DE59409645D1 (en) * 1993-06-29 2001-03-01 Byk Gulden Lomberg Chem Fab Substituierte arylthioalkylthiopyridine
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
EP1047692B1 (de) 1998-01-14 2004-07-21 The Uab Research Foundation Verfahren zur herstellung und screening von inhibitoren des bakteriellen nad synthetase enzyms, verbindungen daraus und methoden zur behandlung bakterieller und mikrobieller infektionen mit diesen inhibitoren
FI104384B (fi) 1998-06-05 2000-01-14 Valmet Corp Laitteisto ja menetelmä viiraveden ja tuoremassan sekoittamiseksi viirakaivon jälkeisessä kanavassa
CA2419067C (en) * 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
CN1243749C (zh) 2001-09-18 2006-03-01 泽里新药工业株式会社 苯并咪唑衍生物
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2005521662A (ja) * 2002-01-25 2005-07-21 サンタラス インコーポレイティッド プロトンポンプ阻害剤の経粘膜送達
US8367111B2 (en) * 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
EP1648417A4 (de) * 2003-07-18 2010-01-20 Santarus Inc Pharmazeutische formulierung und verfahren zur behandlung von säurebedingten gastrointestinalen erkrankungen
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MXPA06000529A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas.
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
EP1718303A4 (de) * 2004-02-10 2010-09-01 Santarus Inc Kombination eines protonenpumpenhemmers, puffermittels und einem nichtsteroidalen entzündungshemmenden mittel
CA2561700A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US8747895B2 (en) * 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ709754A (en) 2004-10-21 2017-02-24 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
CN101309917B (zh) * 2005-10-06 2013-09-11 奥斯拜客斯制药有限公司 具有增强治疗性质的胃h+，k+-atp酶氘代抑制剂
PL2003130T3 (pl) * 2006-03-10 2012-04-30 Link Genomics Inc Nowa pochodna pirydyny o aktywności przeciwko helicobacter pylori
CA2654402A1 (en) * 2006-06-01 2007-12-06 Adel Penhasi Multiple unit pharmaceutical formulation
CA2654450A1 (en) * 2006-06-05 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2068841B1 (de) 2006-10-05 2018-09-26 Santarus, Inc. Neuartige formulierungen von protonenpumpenhemmern und verfahren zu ihrer verwendung
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
KR101353572B1 (ko) * 2009-04-09 2014-01-22 링크 제노믹스 가부시키가이샤 피리딘티오 유도체 및 이를 함유하는 항-헬리코박터피로리 작용을 가지는 의약 조성물
KR101765357B1 (ko) 2009-12-02 2017-08-04 아데어 파마수티컬스 에스.알.엘. 펙소페나딘 마이크로캡슐 및 그것을 함유하는 조성물
US20110212171A1 (en) * 2010-01-08 2011-09-01 Eurand, Inc. Taste masked topiramate composition and an orally disintegrating tablet comprising the same
EP3288556A4 (de) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Oral zerfallende zusammensetzungen
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS62277322A (ja) * 1986-02-13 1987-12-02 Takeda Chem Ind Ltd 安定化された腸溶性抗潰瘍固形組成物
JP2694361B2 (ja) * 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤

Also Published As

Publication number Publication date
US5013743A (en) 1991-05-07
FI104045B (fi) 1999-11-15
FI100168B (fi) 1997-10-15
DE69014141T2 (de) 1995-05-24
EP0382489B1 (de) 1994-11-17
EP0382489A2 (de) 1990-08-16
FI900662A0 (fi) 1990-02-09
EP0382489A3 (de) 1991-06-12
ES2066120T3 (es) 1995-03-01
CA2009741C (en) 1999-03-23
CA2009741A1 (en) 1990-08-10
FI104045B1 (fi) 1999-11-15
DK0382489T3 (da) 1995-01-16
GR3014973T3 (en) 1995-05-31
NO900639D0 (no) 1990-02-09
ATE114114T1 (de) 1994-12-15
FI940951A (fi) 1994-02-28
NO900639L (no) 1990-08-13
FI940951A0 (fi) 1994-02-28

Similar Documents

Publication Publication Date Title
ATE114114T1 (de) Verwendung von benzimidazol-derivaten als antibakterielle mittel.
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
NZ228893A (en) Substituted quinoline and naphthyridine derivatives and pharmaceutical compositions
BG106390A (en) Novel spiro compounds
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
PT867436E (pt) Derivados de n-aril-piperidina e sua utilizacao como ligandos do receptor 5-ht1b
DE69716925T2 (de) Isoxazoline derivate und ihre verwendung als antimikroben
NO934718L (no) Nye HIV protease inhibitorer
DE69231422D1 (de) Pyridoncarbonsäurederivate
YU83993A (sh) Novi derivati piridon organske kiseline
ATE159728T1 (de) Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
ATE209633T1 (de) Pyridinderivate,als arzneimittel zur behandlung von geschwüren und als antibakterielle mittel
FI941963A (fi) Pyridiinijohdannaiset, niiden valmistus ja käyttö
DE69017627T2 (de) Isochinolinderivate und ihre Salze als Proteasehemmer.
ATE275560T1 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
DE69711506T2 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ATE222255T1 (de) 14-substituierte marcfortine und derivate als antiparasitäre mittel
DE69213049D1 (de) Isoquinolinderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: LANSOPRAZOL IN KOMBINATION MIT AMOXICILLIN UND CLARITHROMYCIN; REGISTRATION NO/DATE: 36286.00.00, 36286.01.00, 36288.00.00, 36288.01.00, 38409.00.00, 38409.01.00, 38411.00.00, 38411.01.00; 19980825

Spc suppl protection certif: 199 75 016

Filing date: 19990224

Free format text: PRODUCT NAME: LANSOPRAZOL IN KOMBINATION MIT CLARITHROMYCIN UND METRONIDAZOL; REGISTRATION NO/DATE: 36286.00.00, 36286.01.00, 36288.00.00, 36288.01.00, 38409.00.00, 38409.01.00, 38411.00.00, 38411.01.00; 19980825

Spc suppl protection certif: 199 75 018

Filing date: 19990224

V472 Application for supplementary protection certificate rejected

Free format text: PRODUCT NAME: LANSOPRAZOL IN KOMBINATION MIT AMOXICILLIN UND CLARITHROMYCIN; REGISTRATION NO/DATE: 36286.00.00, 36286.01.00, 36288.00.00, 36288.01.00, 38409.00.00, 38409.01.00, 38411.00.00, 38411.01.00; 19980825

Spc suppl protection certif: 199 75 016

Filing date: 19990224

8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP

V472 Application for supplementary protection certificate rejected

Free format text: PRODUCT NAME: LANSOPRAZOL IN KOMBINATION MIT CLARITHROMYCIN UND METRONIDAZOL; REGISTRATION NO/DATE: 36286.00.00, 36286.01.00, 36288.00.00, 36288.01.00, 38409.00.00, 38409.01.00, 38411.00.00, 38411.01.00; 19980825

Spc suppl protection certif: 199 75 018

Filing date: 19990224